Miedzyleski Szpital Specjalistyczny w Warszawie

Warsaw 4749

0 studies enrolling now · 7 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Diabetic Nephropathies, Focal Segmental Glomerulosclerosis (FSGS), NMO Spectrum Disorder (NMOSD), Neuromyelitis Optica (NMO), Neuromyelitis Optica Spectrum Disorder, Prostate Cancer Metastatic, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD) — Completed
• A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS) — Stopped early
• Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD) — Completed
• A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD — Stopped early
• A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer — Completed
• A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy — Completed
• Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus — Completed